Larimar Therapeutics (LRMR) EPS (2014 - 2026)
Larimar Therapeutics (LRMR) EPS from Jun 30, 2014 to Mar 31, 2026. The TTM Larimar Therapeutics (LRMR) EPS is -$2.00. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Larimar Therapeutics (LRMR) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +34.39% |
| 3 Years TTM | +24.01% |
| 5 Years TTM | -8.46% |
| 10 Years TTM | -3.58% |
| All Time TTM | -1.20% |
Annual EPS change of Larimar Therapeutics (LRMR)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.29 | -85.70% |
| 2025 | -$1.99 | +57.86% |
| 2024 | -$1.26 | +50.09% |
| 2023 | -$0.84 | +3.00% |
| 2022 | -$0.82 | -71.43% |
| 2021 | -$2.86 | +3.44% |
| 2020 | -$2.76 | -27.20% |
| 2019 | -$3.80 | +592.66% |
| 2018 | -$0.55 | -71.04% |
| 2017 | -$1.89 | -10.62% |
| 2016 | -$2.12 | -22.35% |
| 2015 | -$2.73 | +71.03% |
| 2014 | -$1.59 | N/A |
Comparison Larimar Therapeutics (LRMR) five years EPS CAGR with competitors
Larimar Therapeutics (LRMR) five years EPS CAGR is -8.46%.